ES2062135T3 - Derivados del acido tienilacetico, procedimiento para su obtencion, su empleo, asi como medicamentos que contienen este y su obtencion. - Google Patents

Derivados del acido tienilacetico, procedimiento para su obtencion, su empleo, asi como medicamentos que contienen este y su obtencion.

Info

Publication number
ES2062135T3
ES2062135T3 ES90104323T ES90104323T ES2062135T3 ES 2062135 T3 ES2062135 T3 ES 2062135T3 ES 90104323 T ES90104323 T ES 90104323T ES 90104323 T ES90104323 T ES 90104323T ES 2062135 T3 ES2062135 T3 ES 2062135T3
Authority
ES
Spain
Prior art keywords
obtaining
well
denotes
derivatives
tenylacetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90104323T
Other languages
English (en)
Inventor
Rudi Dr Beyerle
Karl Dr Schonafinger
Ursula Dr Schindler
Bernd Dr Jablonka
Jeffery Dr Troke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Cassella Farbwerke Mainkur AG
Original Assignee
Cassella AG
Cassella Farbwerke Mainkur AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella AG, Cassella Farbwerke Mainkur AG filed Critical Cassella AG
Application granted granted Critical
Publication of ES2062135T3 publication Critical patent/ES2062135T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL PRESENTE INVENTO CONCIERNE A DERIVADOS DEL ACIDO TIENILACETICO, DE FORMULA GENERAL I (FORMULA), EN LA QUE: X SIGNIFICA -O- O -NH-; R1 ES HIDROGENO, EL GRUPO -CH2-CO-R3 O BIEN EL GRUPO -CO-CH2-NH2; R2 ES HIDROGENO, UN ALQUILO DE C1-C4 O UN RESTO R1 Y R3 ES (C1-C4)-ALCOXI; HIDROXI O AMINO, NO PUDIENDO SER R1 Y R2 A LA VEZ HIDROGENO CUANDO X SIGNIFIQUE O. TAMBIEN CONCIERNE A SUS SALES TOLERABLES EN FARMACIA, AL PROCEDIMIENTO DE PRODUCCION DE AQUELLOS, A SU UTILIZACION, ASI COMO A LOS MEDICAMENTOS QUE LOS CONTIENEN Y A SU PRODUCCION.
ES90104323T 1989-03-16 1990-03-07 Derivados del acido tienilacetico, procedimiento para su obtencion, su empleo, asi como medicamentos que contienen este y su obtencion. Expired - Lifetime ES2062135T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3908547A DE3908547A1 (de) 1989-03-16 1989-03-16 Thienylessigsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung

Publications (1)

Publication Number Publication Date
ES2062135T3 true ES2062135T3 (es) 1994-12-16

Family

ID=6376450

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90104323T Expired - Lifetime ES2062135T3 (es) 1989-03-16 1990-03-07 Derivados del acido tienilacetico, procedimiento para su obtencion, su empleo, asi como medicamentos que contienen este y su obtencion.

Country Status (13)

Country Link
US (1) US5015659A (es)
EP (1) EP0387677B1 (es)
JP (1) JP2930214B2 (es)
KR (1) KR0150002B1 (es)
AT (1) ATE102939T1 (es)
CA (1) CA2012313C (es)
DD (1) DD292908A5 (es)
DE (2) DE3908547A1 (es)
ES (1) ES2062135T3 (es)
HU (1) HU204808B (es)
IL (1) IL93748A0 (es)
PT (1) PT93456A (es)
ZA (1) ZA901981B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402925B (de) * 1995-05-26 1997-09-25 Chemie Linz Gmbh L-aspartyl-l-thienylalaninmethylester, verfahren zu deren herstellung und verwendung als süssstoff
DE19622354A1 (de) * 1996-06-04 1997-12-11 Bayer Ag Halogenthiophen-Derivate
EP2066619A2 (en) * 2006-11-02 2009-06-10 Arete Therapeutics, INC. Soluble epoxide hydrolase inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2351952A1 (fr) * 1975-09-12 1977-12-16 Nobel Hoechst Chimie Procede de fabrication de derives n-acyles de glycines a substituees par des radicaux aromatiques
EP0067641A3 (en) * 1981-06-17 1983-03-09 Beecham Group Plc Amino acids
DE3132882A1 (de) * 1981-08-20 1983-03-03 Cassella Ag, 6000 Frankfurt Neue piperazinone, ihre herstellung und verwendung

Also Published As

Publication number Publication date
JP2930214B2 (ja) 1999-08-03
HU204808B (en) 1992-02-28
ATE102939T1 (de) 1994-04-15
ZA901981B (en) 1990-11-28
IL93748A0 (en) 1990-12-23
DE3908547A1 (de) 1990-09-20
KR0150002B1 (ko) 1998-10-15
DD292908A5 (de) 1991-08-14
EP0387677A2 (de) 1990-09-19
KR900014356A (ko) 1990-10-23
CA2012313C (en) 1998-10-06
DE59004965D1 (de) 1994-04-21
EP0387677B1 (de) 1994-03-16
HUT53096A (en) 1990-09-28
CA2012313A1 (en) 1990-09-16
HU901424D0 (en) 1990-06-28
US5015659A (en) 1991-05-14
EP0387677A3 (en) 1990-12-05
PT93456A (pt) 1990-11-07
JPH02273669A (ja) 1990-11-08

Similar Documents

Publication Publication Date Title
BR9907270A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto
MX173630B (es) Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
NZ229787A (en) Amino ether diphosphonic acid derivatives and pharmaceutical compositions
NO883073D0 (no) 3-desmetyl-mevalonsyrederivater, fremgangsmaate til deres fremstilling samt deres anvendelse som mellomprodukter.
CA2054341A1 (fr) Applications de derives d'acides alkanopolycarboxyliques comme agents de reticulation de la cellulose, nouveaux derives et apprets textiles
PT90478A (pt) Processo para a preparacao de derivados da purina e de composicoes farmaceuticas que os contem
ES2061581T3 (es) Un procedimiento para preparar un compuesto cefem.
ES8406075A1 (es) Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.
AR015668A1 (es) Sal de hemisulfato de (1s,4r)-cis-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]-2-ciclopenten-1-metanol y formulacion farmaceutica que la contiene
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2062135T3 (es) Derivados del acido tienilacetico, procedimiento para su obtencion, su empleo, asi como medicamentos que contienen este y su obtencion.
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
IL108856A0 (en) Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
ES2055429T3 (es) Proceso para preparar derivados del acido 9-alfa-hidroxi-3-oxo-4,24(25)-estigmastadieno-26-oico, asi como composiciones farmaceuticas que contienen estos compuestos.
DK114286D0 (da) Pyridylmethylnaphthylderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler
EP0328913A3 (de) Neue basisch substituierte 5-Halogen-Thienoisothiazol-3(2H)-on-1,1-dioxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DK286880A (da) Phosphonomyresyrehydrazider fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
AU579997B2 (en) Iminosulphonamides and processes for the manufacture thereof, pharmaceutical preparations containing such compounds, and their use
ZA902167B (en) Thienylpiperazines,process for the preparation thereof,the use thereof,and pharmaceuticals containing these and the preparation thereof
PT88976A (pt) Processo para a preparacao de derivados de tienoimidazol substituidos e de composicoes farmaceuticas que os contem
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them
DK98788D0 (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 387677

Country of ref document: ES